A farkon barkewar cutar, Foregene ya mai da hankali sosai a kai, kuma ya shirya binciken kimiyya nan da nan don saka hannun jari a cikin R&D na sabbin kayan gano ƙwayoyin acid nucleic.Dangane da shekarun hazo na fasaha da gogewa, ƙungiyar ta yi amfani da fasaha ta PCR ta atomatik don haɓaka sabon kayan gano coronavirus (SARS-CoV-2).

Wannan kit ɗin ba ya buƙatar cire acid nucleic daga samfurin, kuma yana iya aiwatar da gano PCR mai kyalli na ainihi bayan sauƙaƙe aikin sakin nucleic acid, wanda ke sauƙaƙa tsarin aiwatar da samfur mai wahala, yana guje wa asarar nucleic acid na samfurin, kuma ya sami sakamakon gwajin a cikin awa 1, musamman dacewa da buƙatun gwaji mai sauri.

Tare da yaduwar cutar a duniya, a matsayinta na memba na kamfanonin IVD na kasar Sin, Foregene kuma ya dauki muhimmin aiki na yaki da cutar a duniya.Kit ɗin ya sami takardar shedar EU CE a ƙarshen Maris.A tsakiyar Afrilu, Foregene tare da BIOWALKER PTE LTD, Singapore, sun wuce Hukumar Kimiyyar Kiwon Lafiya (HSA) ta Singapore (Hukumar Kimiyyar Kiwon Lafiya, HSA), wanda kuma ke nufin cewaForegene na iya ba da taimako ga ƙarin ƙasashen ketare waɗanda ke buƙatar kayan rigakafin ƙwayoyin cuta.

A nan gaba, Foregene zai ci gaba da haɓaka halayen kimiyya kuma ya ci gaba da samar da samfurori da ayyuka tare da ingantaccen aiki da ingantaccen inganci ga manyan kasuwannin biyu na binciken kimiyya da ganewar asali.